Diabetes Pharmacist : Diabetes Pharmacist Blog : Focus Express Mail Pharmacy : Insulin Pumps, Diabetes Supplies and Information

A new drug  for both Type 1 and Type II diabetes,called Exsulin, is in the "pipeline" and could be sent to the FDA for approval in a few years.  Alexander Fleming, MD, former US Food and Drug Administration official and Exsulin Corp. Chief Medical Officer, said "the drug causes the cells in the pancreas to develop into insulin-secreting cells.This is actually a natural hormone we’re developing as a therapy.”  Exsulin will be injected like insulin, but it won't have any direct effect on blood sugar. 

For information on diabetes medications and diabetes testing supplies available at Focus Express Mail Pharmacy click here!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

A newly approved diabetes drug, Onglyza, is now available in U.S. pharmacies, effective Friday August 14, 2009.

Bristol Myers-Squibb and AstraZeneca PLC, which co-developed and will co-market the drug, said that Onglyza was approved as an adjunct to diet and exercise to improve blood-sugar control in adults for the treatment of type 2 diabetes mellitus.

It belongs to a class of drugs known as DPP-4 inhibitors, and will compete directly with the only other such drug on the market, Merck & Co.'s (MRK) Januvia, which has had the DPP-4 market to itself since it was introduced in 2006.

Click here to learn more about diabetes medications available through Focus Express Mail Pharmacy!

• Email This
• Print
• Comments
• Trackbacks
• Share Link